In the service of Health

 
2015 is the 20th anniversary of MédiS laboratories.

2015 is the 20th anniversary of MédiS laboratories.

"It‘s been 20 years ago when MédiS was just an ambition with vague outline, A lined intuition of a profound conviction of success of the dream of my life..." Lassaad BOUJBEL | Founder and Pharmacist MédiS CEO

Lire la suite

Quality Control Laboratory

Quality Control Laboratory

The quality control department, within MédiS Laboratories, is one of the complex systems of quality evaluation in its widest sense, ensuring diverse activities of control and expertise…

Lire la suite

In the service of Health

Founded in 1995, MédiS has obtained the operating license in June 1999. The first Market Authorization dates back to the month of February 2000. Currently, Médis has a large portfolio of proven products as well as a wide sales network.

Read More

Our Strengths

A wide range of products

A wide range of products

Our range of generic drugs currently includes 60 products with 200 different presentations and 17 key therapeutic areas ... Read more

International Certifications

International Certifications

MediS is certified:

  • GMP Europe
  • ISO 9001:2000
  • ISO 14001:2004
  • OHSAS 18001:2007

Read more

Our people and our shared values

Our people and our shared values

MediS currently has 600 employees’ meadows with a framing rate reaching 50%.... Read more

News

02.03.2015

Medis launches cis-atracurium : CISATREX®

Enhanced by the great and positive experience in the field of anesthesiology and medical reanimation, MédiS proves once again that it is  the main actor  in this area by launching his CISATREX® 10mg / 5ml,...

02.03.2015

The Management of PAIN, IS CONTINUING….

MédiS philosophy, which becomes a reality, is to by provide patients high quality medicines while ensuring the economy in the management of their disease such as pain. Indeed, MédiS invests again in the management of pain by...

02.03.2015

Médis Laboratories Launches 1st recombinant human erythropoietin produced in Tunisia

After granting the Marketing Authorization of THE FIRST Human Recombinant alpha Erythropoietin (EPO), MédiS becomes the FIRST Tunisian pharmaceutical company to produce and market its biosimilar EPO commercially appointed as...